FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Clinical trial NCT00233818 · COMPLETED

Trial details

NCT number: NCT00233818
Sponsor: Cordis US Corp.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2000-02-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.